Program at a Glance

WEDNESDAY, JULY 25

Dinner Symposium:
Driving Collaborative Breast Cancer Research in Latin America

Introduction
Orlando E. Silva, MD

Being a Clinical Research Center of Excellence: The International Requirements for Institutional Certification and the Peruvian Experience
Henry L Gomez, MD

Conducting International Clinical Trials in Latin America According to Good Clinical Practice: Lessons Learned from Different Countries

• The Mexican Experience - Dolores Gallardo, MD
• The Brazilian Experience - TBC

From the Eyes of a Principal Investigator: The Academic Perspective
Martine J. Piccart-Gebhart, MD, PhD

From the Eyes of the Industry: The Industry’s Perspective            Jorge Otero, MD

Questions and Challenges in Certifying Your Institution
Panel discussion:
Chaired by Javier Cortes
Panelists: Drs. Gomez, Gallardo, Lucas, Piccart-Gebhart, Otero

THURSDAY, JULY 26

Welcome and Opening Remarks
Orlando E. Silva, MD

DIFFERENT APPROACHES TO BREAST CANCER: LEARNING FROM OUR GLOBAL NEIGHBORS

Welcome and Introduction
Henry L. Gomez, MD

Incidence and Treatment Practices in Breast Cancer: The Latin American Experience
Sergio Rodriguez-Cuevas, MD

Management of Breast Cancer in Arab Countries and Worldwide: Resources, Guidelines and Implementation
Nagi El Saghir, MD

Frequency and Treatment Approaches for Breast Cancer in Asia Rene Muňoz-Bermeo, MD

Panel Discussion

Coffee Break and Exhibits

RECENT ADVANCES IN SURGICAL AND RADIATION TREATMENTS FOR BREAST CANCER

Welcome and Introduction

Controversies in Breast Imaging – Tomosynthesis
Monica Yepes, MD

Clinical Decisions in Diagnosis - Sentinel Lymph Node Biopsy vs. Axillary Dissection in Breast Cancer
Stefano Zurrida, MD

Prevention and Treatment of Lymphedema in Patients with Breast Cancer
Dido Franceschi, MD

The Future of Breast Surgery in Breast Cancer
Benigo Acea, MD

Integrating Radiation into the Treatment Paradigm: Radiation after Mastectomy and Partial Breast Irradiation after Breast Reconstruction
Christiane Takita, MD

CONCURRENT SESSIONS

Medical Oncology Track: Part 1
POST SURGICAL ADJUVANT THERAPY

Welcome and Introduction
Javier Cortes, MD

Assessing Recurrence Risk and the 2012 Standard of Care for Adjuvant Chemotherapy
Vicente Valero, MD

Adjuvant Hormonal Therapy in the Treatment of Pre- and Post-menopausal Breast Cancer
William Gradishar, MD

Targeting Adjuvant Therapy to the HER Superfamily and Overcoming Upfront HER2 Resistance
Martine J. Piccart-Gebhart, MD, PhD

Targeting Locally-Advanced Triple-negative Breast Cancer with Adjuvant Therapies: Current and Near-Future Approaches            Kimberly Blackwell, MD

Osteoclast Modulating Agents for Primary Breast Cancer            Martine J. Piccart-Gebhart, MD, PhD

SURGICAL TRACK PART 1

Welcome and Introduction
Jorge Zavala, MD

Indications and Contraindications for Oncoplastic Surgery in Breast Conserving Therapy of Breast Carcinomas
Benigno Arcea, MD

Roll of Biomarkers and Histologic Features Predicting Local Recurrence in Breast Conservative Surgery
Carmen Gomez-Fernandez, MD

Not only Good Results: How to Treat Complications Arising in Oncoplastic Surgery
Roundtable Discussion: Benigno Arcea, MD, Benjamin Paez, MD, Fernando Magallanes, MD, Jorge Zavala, MD

Internal Quadrant Tumors – Video Case Discussions            Roundtable Discussion: Benigno Acea, MD, Stefano Zurrida, MD, Christiane Takita, MD

FRIDAY, JULY 27

IMPROVING SURVIVAL THROUGH DIAGNOSTICS AND PATHOLOGY

Welcome and Introduction
Carmen Gomez-Fernandez, MD

Breast Cancer Stem Cells: Clinical Understanding and Current Therapeutic Utility
Carmen Gomez-Fernandez, MD\

Circulating Tumor Cells, their Detection, and their Significance in Breast Cancer
Horacio Astudillo De la Vega

Breast Cancer Pathology for the Clinical Oncologist: Understanding Molecular Subtypes
Carmen Gomez-Fernandez, MD

Recent Developments in the Management of Breast Cancer: Highlights from SABCS and ASCO
Hyman Muss, MD

KEYNOTE SYMPOSIUM

Welcome and Introduction
Orlando E. Silva, MD

Nipple-sparing Mastectomy
Umberto Veronesi, MD

Fifth Umberto Veronesi Award Presentation for the Future Fight Against Breast Cancer
Presented by Charles L. Vogel, MD

Translating Cutting-Edge Medical Advances into Monday Morning’s Clinic – A Personal Perspective
Martine J. Piccart-Gebhart, MD, PhD

Late-Breaking Abstract
Orlando E. Silva, MD

ORLANDO G. SILVA BEST POSTER AWARDS

Introduction
Orlando E. Silva, MD

Q&A with Author of #1 Poster
Q&A with Author of #2 Poster
Q&A with Author of #3 Poster

CONCURRENT SESSIONS

Medical Oncology Track: Part 2
METASTATIC BREAST CANCER

Welcome and Introduction
Vicente Valero, MD

Overcoming Resistance to Endocrine Therapy in Metastatic Breast Cancer
Charles L. Vogel, MD

Chemotherapy in the Metastatic Patient: Treatment Options in 2012 and Beyond
William Gradishar, MD

Development of New Treatment Algorithms for Triple Negative and BRCA-deficient Breast Cancers
Kimberly Blackwell, MD

Understanding and Surmounting Resistance to anti-HER2 Therapy 
Javier Cortes, MD

Angiogenesis in Metastatic Breast Cancer: What is the Current and Future Role for Anti-Angiogenic Therapy?
Mark Pegram, MD

SURGICAL TRACK PART 2

Welcome and Introduction
Sergio Rodriguez-Cuevas, MD

Neoadjuvant and Adjuvant Treatments with Oncoplastic Surgery for Breast Cancer
Javier Cortes, MD

How to Plan Breast Conservative Surgery for Breast Cancer    Benigno Arcea, MD

Tips and Pitfalls on Planning Breast Conservative Surgery            Audience Discussion

Is it Safe to Use Fat Injections for Breast Remolding during Breast Conservative Surgery?
Benjamin Paz of City of Hope, LA

Clinical Debate: Uses of Mastectomy – Why Yes, Why Not             Pro: Benjamin Paz of City of Hope, LA.
Con: Benigno Arcea, MD

Final Touches in Breast Reconstruction: Nipple Areola Complex, Sacrs, Liposuction, and the Submammary Fold
Fernando Magallanes, MD

Conclusions and Take Home Messages
Sergio Rodriguez-Cuevas, MD

SATURDAY, JULY 28

WHAT WILL YOU DO ON MONDAY MORNING?

Welcome and Introduction
Orlando E. Silva, MD

Breast Cancer: Care of Pregnant Patients and Maintaining Fertility in Pre-Menopausal Women with Breast Cancer
Ana Maria Gonzalez-Angulo, MD

Gynecological Issues in Women with Breast Cancer
Hyman Muss, MD

Combining Different Biologics in the Treatment of Breast Cancer – Can We Use Them on Monday?
Mark Pegram, MD

Gene Expression Profiling/TAILOR Rx and MINDACT: Why and When?
Ana Maria Gonzalez-Angulo, MD

Coffee Break

WHAT WILL YOU DO ON MONDAY MORNING? Continued

How Basic Science is Finally Transforming the Care of Women with Breast Cancer
Charles L. Vogel, MD

Neoadjuvant Therapy in HER-2 Positive Breast Cancer: Indications for Use and Current Treatment Approaches
Javier Cortes, MD

Current Standards of Neoadjuvant Therapies in HER-2 Negative Breast Cancer
Jaime de la Garza, MD

Cancer, Nutrition and Lifestyles
Orlando E. Silva, MD

Closing Comments and Adjournment

*Preliminary Program subject to change